-
公开(公告)号:US08758760B2
公开(公告)日:2014-06-24
申请号:US12531507
申请日:2008-03-19
申请人: Toshiro Shirakawa , Masato Kawabata , Tetsuo Takata , Michiko Taniguchi , Asako Okamoto , Masanori Asada , Masaaki Nakatsuji
发明人: Toshiro Shirakawa , Masato Kawabata , Tetsuo Takata , Michiko Taniguchi , Asako Okamoto , Masanori Asada , Masaaki Nakatsuji
CPC分类号: A61K9/4891 , A61K39/0275 , A61K39/0283 , A61K39/107 , A61K47/6901 , A61K2039/522 , A61K2039/523 , A61K2039/542 , Y02A50/472 , Y02A50/476 , Y02A50/482 , Y02A50/484
摘要: The present invention provides an oral vaccine against a bacterial infectious disease (e.g., typhoid fever, cholera, or dysentery). The oral vaccine of the present invention is a capsule formulation in which a transformed microorganism that expresses a flagellin antigen protein or that secretes a flagellin antigen protein out of the cell of the microorganism is encapsulated with an acid-resistant membrane. Examples of the microorganism include intestinal bacteria belonging to the genus Bifidobacterium, the genus Lactobacillus, the genus Lactococcus, and the like. The form of the capsule formulation may be any one of a seamless capsule formulation, a soft capsule formulation, and a hard capsule formulation.
摘要翻译: 本发明提供了针对细菌感染性疾病(例如伤寒,霍乱或痢疾)的口服疫苗。 本发明的口服疫苗是一种胶囊制剂,其中表达鞭毛蛋白抗原蛋白或将鞭毛蛋白抗原蛋白从微生物细胞分泌出来的转化微生物用耐酸膜包封。 微生物的实例包括属于双歧杆菌属,乳杆菌属,乳球菌属等的肠细菌。 胶囊制剂的形式可以是无缝胶囊制剂,软胶囊制剂和硬胶囊制剂中的任何一种。
-
公开(公告)号:US20110311617A1
公开(公告)日:2011-12-22
申请号:US12531507
申请日:2008-03-19
申请人: Toshiro Shirakawa , Masato Kawabata , Tetsuo Takata , Michiko Taniguchi , Asako Okamoto , Masanori Asada , Masaaki Nakatsuji
发明人: Toshiro Shirakawa , Masato Kawabata , Tetsuo Takata , Michiko Taniguchi , Asako Okamoto , Masanori Asada , Masaaki Nakatsuji
IPC分类号: A61K9/48 , A61P37/04 , A61P31/04 , A61K39/112 , A61K39/106
CPC分类号: A61K9/4891 , A61K39/0275 , A61K39/0283 , A61K39/107 , A61K47/6901 , A61K2039/522 , A61K2039/523 , A61K2039/542 , Y02A50/472 , Y02A50/476 , Y02A50/482 , Y02A50/484
摘要: The present invention provides an oral vaccine against a bacterial infectious disease (e.g., typhoid fever, cholera, or dysentery). The oral vaccine of the present invention is a capsule formulation in which a transformed microorganism that expresses a flagellin antigen protein or that secretes a flagellin antigen protein out of the cell of the microorganism is encapsulated with an acid-resistant membrane. Examples of the microorganism include intestinal bacteria belonging to the genus Bifidobacterium, the genus Lactobacillus, the genus Lactococcus, and the like. The form of the capsule formulation may be any one of a seamless capsule formulation, a soft capsule formulation, and a hard capsule formulation.
摘要翻译: 本发明提供了针对细菌感染性疾病(例如伤寒,霍乱或痢疾)的口服疫苗。 本发明的口服疫苗是一种胶囊制剂,其中表达鞭毛蛋白抗原蛋白或将鞭毛蛋白抗原蛋白从微生物细胞分泌出来的转化微生物用耐酸膜包封。 微生物的实例包括属于双歧杆菌属,乳杆菌属,乳球菌属等的肠细菌。 胶囊制剂的形式可以是无缝胶囊制剂,软胶囊制剂和硬胶囊制剂中的任何一种。
-